How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals
In this episode of Cholesterol Conversations, Drs. Marc Bonaca, Pam Taub, and Heather Johnson discuss how multiagent therapy can improve the provision of care in the real world. Covered topics include new data from the 2023 ACC Scientific Sessions on the efficacy of novel agents and the role of com…
The Future of Pharma Trials: Part 1
Roxana Mehran hears predictions from Marc Bonaca, C. Michael Gibson, and Adrian Hernandez.
What is the benefit of starting earlier PCSK9 inhibitors for acute coronary syndromes? - report from ESC2024
Professor Marc Bonaca explains what is the benefit of starting earlier PCSK9 inhibitors for acute coronary syndromes?
Video: https://medicaldigest.org/scientific-contents/interview:what-benefit-starting-earlier-pcsk9-inhibitors-acute-coronary-syndromes-report-esc2024
How Has Antithrombotic Therapy for PAD Changed Over the Last Decade?
Medical therapy is critical in preventing the worst complications of peripheral artery disease (PAD), among them heart attack, stroke, bleeding risk, and leg disease, which could lead to acute limb ischemia and amputation. Blood thinning medications (antithrombotic therapy) have shown rapid evoluti…
Long-Term Adverse Limb Events After Femoral Artery Endovascular Revascularization: The Boston FAROUT Study
This study assessed the relationships of patient, lesion, and procedural characteristics to the subsequent risk of major and minor adverse limb events over the decade after successful endovascular revascularization of the superficial femoral artery for chronic limb-threatening ischemia (CLTI) or l…
Weight Loss Drug Reduces Leg Cramps In Diabetics With PAD
For the first time in over TWO DECADES, there's a new medication treatment approach for peripheral artery disease! The groundbreaking STRIDE Trial has shown that semaglutide significantly improves walking ability and quality of life for those suffering from PAD with type 2 diabetes. JOIN US THURSDA…
Weight Loss Drug Reduces Leg Cramps In Diabetics With PAD
For the first time in over TWO DECADES, there's a new medication treatment approach for peripheral artery disease! The groundbreaking STRIDE Trial has shown that semaglutide significantly improves walking ability and quality of life for those suffering from PAD with type 2 diabetes. JOIN US THURSDA…
STRIDE Trial: Effects of Semaglutide in Patients With Peripheral Artery Disease
Patients with peripheral artery disease (PAD) often experience significant walking difficulties, and there are limited therapies available to improve their mobility. Investigation made through the STRIDE (Effects of Semaglutide on Functional Capacity in Patients With Type 2 Diabetes and Peripheral …
Medicare’s First 10 Negotiable Drugs, Chatbots in Your Practice?
Digital health expert Patty Riskind (CEO, Orbita) digs into three main barriers physicians may perceive in incorporating chatbots into their practice. Virtual assistants, such as chatbots, have changed the way businesses operate, and how people navigate their day-to-day tasks. From making travel pl…
पॉडकास्ट खोज इंजन
आप लोगों, स्थानों या विषयों के आधार पर3,822,630पॉडकास्ट और195,560,864एपिसोड खोजने के लिए हमारी वेबसाइट का उपयोग कर सकते हैं।
ज्ञान में निवेश सबसे अच्छा लाभ देता है, इसलिए मैं पॉडकास्ट सुनता हूँ।
‐ Benjamin "Llamacorn" Franklin
संपादित करें
पॉडकास्ट डेटाबेस को अपडेटेड रखने में मदद के लिए धन्यवाद।
